Global Biologics and Biosimilars Market Study 2015-2025, by Segment (Antibody, Hormone, Growth Factors), by Market (Tumor, DiabetesHormone, Cardiovascular), by Company (Roche, Amgen, AbbVie)

ReportPage
Report ID
45586
Published Date
18-Sep
No of Report Page
89
Report Category
Medical Devices
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details

    Snapshot
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimil

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Biologics and Biosimilars Industry
    1.1.1 Overview
    1.1.2 Products of Major Companies
    1.2 Market Segment
    1.2.1 Industry Chain
    1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
    2 Biologics and Biosimilars Market by Type
    2.1 By Type
    2.1.1 Antibody
    2.1.2 Hormone
    2.1.3 Growth Factors

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample